Phase III study eyes intravitreal therapy for exudative AMD

Anti-VEGF monoclonal antibody fragment improves vision, reduce fluorescein angiographic leakage

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.